SCHEMBL23903174

SCHEMBL23903174

O=c1c2ccccc2[nH]c2nc3ccc(Nc4ccccc4Cl)cc3n12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APAF1 O14727 1/20 0.44
TDP2 O95551 1/20 0.44
CDC25B P30305 1/20 0.44
CASP3 P42574 1/20 0.44
CASP7 P55210 1/20 0.44
CASP9 P55211 1/20 0.44
CASP6 P55212 1/20 0.44
CASP8 Q14790 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
MAPK8 P45983 3/20 0.40
MAPK10 P53779 3/20 0.40
MAPK14 Q16539 3/20 0.40
PTK6 Q13882 3/20 0.40
C1R P00736 3/20 0.40
NPC1 O15118 1/20 0.40
ALDH1A1 P00352 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18934624 0.85 MAPK8 (0.41) APAF1TDP2CDC25BCASP3CASP7
SCHEMBL18934522 0.79 LCK (0.44) APAF1TDP2CDC25BCASP3CASP7
SCHEMBL23903129 0.77 CYP1A1 (0.47) CDC25BMAPK8MAPK10NPC1ALDH1A1
SCHEMBL23902881 0.77 RAB9A (0.49) APAF1TDP2CDC25BCASP3CASP7
SCHEMBL18934883 0.77 MAPK10 (0.44) APAF1TDP2CDC25BCASP3CASP7
SCHEMBL18934627 0.77 MAPK8 (0.41) APAF1TDP2CDC25BCASP3CASP7
SCHEMBL11827448 0.75 KDM4E (0.55) CDC25BMAPK8MAPK10NPC1ALDH1A1
SCHEMBL23903106 0.72 AHR (0.45) CDC25BMAPK8MAPK10ALDH1A1SMN1; SMN2
SCHEMBL18253544 0.70 MAPK8 (0.57) APAF1TDP2CDC25BCASP3CASP7
SCHEMBL11831298 0.69 POLB (0.43) NPC1ALDH1A1RAB9ASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
WO-2021198213-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION DDT, EPCAM, SLC18A3 APAF1 4426/4885TDP2 464/4885CDC25B 3790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.